Federal Reserve “Increasingly Confident” Policy Positioned to Slow Economy, Reduce Inflation; WTI and Brent Rebound from Morning Lows
NEW YORK, NY, November 28, 2023 – PRISM MarketView, a leading provider of unbiased market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities were narrowly mixed in Tuesday afternoon trading as November consumer confidence increased to 102 on the index, ahead of economists’ expectations. The S&P 500 Energy […]
PRISM MarketView Spotlights Significant Market Opportunities in Global Health with Launch of Emerging Public Health Index
NEW YORK, NY, November 14, 2023 – PRISM MarketView, a leader within the financial markets and news community, has debuted its PRISM Emerging Public Health Index. The Public Health segment highlights the most critical health crises impacting the world’s population today – including dementia, diabetes, stroke, hypertension and heart disease – as identified by the […]
PRISM MarketView Insight: Is It Time to Invest in Small-Cap Stocks?
NEW YORK, NY, November 7, 2023 – As the Russell 2000 recently recorded its best week in over two years, investors are turning their attention to the potential end of the Federal Reserve’s interest rate hike cycle. This shift in sentiment has sparked a remarkable surge in previously downtrodden market segments, with the index climbing […]
PRISM MarketView Oil & Gas Index Update: WTI Crude Reverses Gains, Earnings Season in Full Swing
NEW YORK, NY, November 1, 2023 – PRISM MarketView, a leading provider of market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities finished mostly higher in Wednesday afternoon trading, near best levels. The S&P 500 Energy Index closed down (0.33%) versus the S&P 500 which was up +1.05%, […]
PRISM MARKETVIEW’S EMERGING HEALTHCARE INDEX HIGHLIGHTS LIFEMD, INC. AS ITS LARGEST YTD GAINER, UP ~226%
NEW YORK, NY, November 1, 2023 – LifeMD, Inc. is the current YTD leader in the PRISM Emerging Healthcare Index. The company has seen a ~226% increase this year and is trading at approximately $6 per share. This price falls on the higher end of its 52-week range of $1.14 – $7.40 which may indicate the potential for […]
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
NEW YORK, NY, October 24, 2023 – The biotech sector, known for its exponential growth potential, is currently facing highly challenging market conditions. Influences like rising inflation, geopolitical tensions, and looming economic recessions have led to a sharp decline in the sector. Consequently, many small and micro-cap biotech companies are trading at all-time lows, with […]